Ulrike Kappes, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ultraviolet Rays | 3 | 2008 | 1078 | 0.570 |
Why?
|
| Skin | 3 | 2008 | 4466 | 0.290 |
Why?
|
| DNA Glycosylases | 1 | 2005 | 124 | 0.240 |
Why?
|
| Guanine | 1 | 2005 | 278 | 0.230 |
Why?
|
| Methoxsalen | 1 | 2003 | 21 | 0.230 |
Why?
|
| Baths | 1 | 2003 | 53 | 0.220 |
Why?
|
| PUVA Therapy | 1 | 2003 | 101 | 0.220 |
Why?
|
| Cell Transdifferentiation | 1 | 2024 | 185 | 0.220 |
Why?
|
| Troponin C | 1 | 2023 | 24 | 0.220 |
Why?
|
| DNA Damage | 3 | 2008 | 2442 | 0.210 |
Why?
|
| 1-Propanol | 1 | 2001 | 15 | 0.200 |
Why?
|
| Dermatitis, Irritant | 1 | 2001 | 18 | 0.200 |
Why?
|
| Irritants | 1 | 2001 | 43 | 0.200 |
Why?
|
| Sodium Dodecyl Sulfate | 1 | 2001 | 127 | 0.190 |
Why?
|
| Skin Aging | 1 | 2003 | 141 | 0.190 |
Why?
|
| Sunlight | 1 | 2003 | 337 | 0.190 |
Why?
|
| Photography | 1 | 2003 | 530 | 0.170 |
Why?
|
| Skin Transplantation | 1 | 2004 | 1083 | 0.160 |
Why?
|
| Photosensitizing Agents | 1 | 2003 | 618 | 0.160 |
Why?
|
| Mutation | 4 | 2023 | 29957 | 0.160 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2023 | 819 | 0.140 |
Why?
|
| Transplantation, Heterologous | 1 | 2004 | 2379 | 0.130 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2024 | 1455 | 0.120 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2024 | 1403 | 0.120 |
Why?
|
| Water Loss, Insensible | 2 | 2004 | 12 | 0.110 |
Why?
|
| Pyrimidine Dimers | 1 | 2006 | 18 | 0.070 |
Why?
|
| Kidney Transplantation | 1 | 2001 | 4214 | 0.070 |
Why?
|
| Disease Models, Animal | 1 | 2004 | 18137 | 0.060 |
Why?
|
| Electric Capacitance | 1 | 2004 | 14 | 0.060 |
Why?
|
| Genes, p53 | 1 | 2006 | 713 | 0.060 |
Why?
|
| Body Water | 1 | 2004 | 341 | 0.050 |
Why?
|
| Skin Absorption | 1 | 2003 | 94 | 0.050 |
Why?
|
| Biological Availability | 1 | 2003 | 395 | 0.050 |
Why?
|
| Half-Life | 1 | 2003 | 652 | 0.050 |
Why?
|
| Aging | 1 | 2001 | 8652 | 0.050 |
Why?
|
| Skin Physiological Phenomena | 1 | 2003 | 188 | 0.050 |
Why?
|
| Dermatofibrosarcoma | 1 | 2002 | 48 | 0.050 |
Why?
|
| Dermatitis, Occupational | 1 | 2001 | 26 | 0.050 |
Why?
|
| Epidermis | 1 | 2004 | 529 | 0.050 |
Why?
|
| Cell Line | 2 | 2006 | 15620 | 0.050 |
Why?
|
| Administration, Cutaneous | 1 | 2003 | 713 | 0.050 |
Why?
|
| Colorimetry | 1 | 2001 | 153 | 0.050 |
Why?
|
| Erythema | 1 | 2001 | 262 | 0.040 |
Why?
|
| Stillbirth | 1 | 2023 | 367 | 0.040 |
Why?
|
| Mosaicism | 1 | 2023 | 466 | 0.040 |
Why?
|
| Mice, SCID | 1 | 2004 | 2627 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2003 | 1635 | 0.040 |
Why?
|
| Scleroderma, Systemic | 1 | 2002 | 344 | 0.040 |
Why?
|
| Pulmonary Fibrosis | 1 | 2002 | 506 | 0.040 |
Why?
|
| Infant Mortality | 1 | 2023 | 756 | 0.040 |
Why?
|
| Water | 1 | 2003 | 1407 | 0.040 |
Why?
|
| Skin Neoplasms | 2 | 2008 | 5799 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2003 | 4035 | 0.030 |
Why?
|
| Uterine Neoplasms | 1 | 2024 | 1439 | 0.030 |
Why?
|
| Base Sequence | 1 | 2006 | 12444 | 0.030 |
Why?
|
| Skin Diseases | 1 | 2003 | 1089 | 0.030 |
Why?
|
| Molecular Sequence Data | 1 | 2006 | 17624 | 0.030 |
Why?
|
| Humans | 10 | 2024 | 760613 | 0.020 |
Why?
|
| Graft Survival | 1 | 2001 | 3795 | 0.020 |
Why?
|
| Female | 7 | 2024 | 391246 | 0.020 |
Why?
|
| Graft Rejection | 1 | 2001 | 4426 | 0.020 |
Why?
|
| Mice | 2 | 2005 | 81209 | 0.020 |
Why?
|
| Survival Rate | 1 | 2001 | 12810 | 0.020 |
Why?
|
| Middle Aged | 4 | 2024 | 220359 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2003 | 20080 | 0.010 |
Why?
|
| Age Factors | 1 | 2001 | 18413 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2002 | 9278 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2001 | 22052 | 0.010 |
Why?
|
| Animals | 2 | 2005 | 167960 | 0.010 |
Why?
|
| Incidence | 1 | 2001 | 21391 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2023 | 26179 | 0.010 |
Why?
|
| Time Factors | 1 | 2003 | 40139 | 0.010 |
Why?
|
| Pregnancy | 1 | 2023 | 29746 | 0.010 |
Why?
|
| Thigh | 1 | 2002 | 240 | 0.010 |
Why?
|
| Prognosis | 1 | 2001 | 29661 | 0.010 |
Why?
|
| Male | 3 | 2003 | 359718 | 0.010 |
Why?
|
| Aged | 2 | 2003 | 169143 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2003 | 58980 | 0.010 |
Why?
|
| Adult | 2 | 2003 | 220007 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2002 | 13262 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2001 | 15760 | 0.010 |
Why?
|
| Adolescent | 1 | 2003 | 87809 | 0.010 |
Why?
|
| Risk Factors | 1 | 2001 | 74333 | 0.010 |
Why?
|